Please assess the completion status of the following clinical trial:

Trial Title: Effect of Ultrasound-guided Hyaluronic or Corticosteroid Injections in Patients With Chronic Subacromial Bursitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. shoulder pain for more than 1 month~2. age ≥ 20 years old~3. painful abduction or internal rotation with a visual analog scale (VAS) pain score ≥4~4. the presence of a painful arc of motion or pain at the middle to terminal range of shoulder abduction or internal rotation with a soft end feel~5. tenderness over the subacromial bursa~6. a reduction in pain of ≥40% on active shoulder abduction or internal rotation at the terminal range after injection of 3ml of 1%lidocain into the SASD bursa under ultrasound (US) guidance.~Exclusion Criteria:~1. a history of uncontrolled chronic diseases, e.g., malignant neoplasms, blood dyscrasia, and infection~2. previous surgery of the affected shoulder~3. any evidence of a rotator cuff tear or tendinopathy, demonstrated by positive resistive tests or sonographic findings~4. calcification of the rotator cuff, demonstrated by x-ray or sonographic findings~5. the presence of arthritis, such as inflammatory arthritis (e.g., rheumatoid arthritis, seronegative spondyloarthropathy, or crystal-related arthropathy), osteoarthritis, frozen shoulder, subacromial spurs, or deformity of the acromion~6. the presence of instability of the affected shoulder~7. a previous fracture near the shoulder region~8. the presence of cervical radiculopathy or myelopathy~9. having received a corticosteroid or hyaluronic acid subacromial or shoulder joint injection in the past 3 months

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- corticosteroids SASD injection (Type: EXPERIMENTAL): under US guidance 2ml triamcinolone (1ml/10mg), 0.5ml distilled water and 1ml 1% lidocaine
- hyaluronic acid (ARTZ) SASD injection (Type: EXPERIMENTAL): under US guidance 2.5ml HA (ARTZ, 1% sodium hyaluronate solution, 10mg/mL, molecular weight 0.9x106Da) and 1ml 1% lidocaine
- normal saline SASD injection (Type: PLACEBO_COMPARATOR): under US guidance 2.5ml normal saline and 0.5ml distilled water and 1ml 1% lidocaine

Based on this trial design, predict the completion outcome and termination type (if applicable).